Rex-Osprey to launch 'first-ever staked crypto ETF in the US' for trading on Wednesday
Quick Take “Coming Wednesday: The First-Ever Staked Crypto ETF in the U.S.!” the firm said on Monday. The SEC is also currently reviewing a proposal to convert Grayscale’s Digital Large Cap Fund and faces a deadline on whether to approve the fund to list and trade on Wednesday.
A Solana exchange-traded fund that will track the price and deliver staking yields to holders will begin trading on Wednesday, according to REX Shares.
"Coming Wednesday: The First-Ever Staked Crypto ETF in the U.S.!" the firm said Monday on X.
REX Shares and Osprey Funds filed with the U.S. Securities and Exchange Commission in May to create C-corporation ETFs that would invest in Solana, and another that invests in Ethereum. The funds would also stake some of the assets for additional yield generation.
The SEC is also considering a wide array of crypto ETFs , from ones that track SOL to DOGE in the face of a friendlier regulatory environment for crypto following President Donald Trump's inauguration in January. The SEC is also currently reviewing a proposal to convert Grayscale's Digital Large Cap Fund and faces a deadline on whether to approve the fund to list and trade on Wednesday. That fund holds a basket of crypto from bitcoin to Solana to XRP.
Rex-Osprey's approach is different from other proposals and sidesteps an approval process with a clever legal workaround; unlike most ETFs, the funds elect to be taxable C-corps. As such, staking distributions to holders will be taxed inside the fund before being distributed to holders as dividends. The management fees for both funds are 0.75%, though the income-tax accrual will cause overall fees to be higher in most cases, according to previous reporting from The Block.
The SEC previously warned that Rex Shares and Osprey Funds ETF may not meet the basic legal definition of an ETF, though that appears to have been resolved.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. Stock IPO Preview | From Losses to Net Profit of 5.46 Million: The "Three-Dimensional" Platform Business Strategy with a Taste for Golf
Crossing the break-even line, the growth inflection point has arrived.
Core CPI Exceeds Expectations Again, Fed Hawks Loud! 2027 FOMC Voting Member Directly Calls Inflation Hot
Austan Goolsbee, President of the Chicago Federal Reserve, stated that officials must address the issue of high inflation, and described the October consumer price report as worrisome.
Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality
The FDA requires all GLP-1 drugs to include a warning about the rare eye disease NAION. Novo Nordisk and Eli Lilly deny any causality, while Citi states that the impact on adoption is limited.
Crypto prices
More
